Author:
Jain Sneha Rajiv,Sim Wilson,Ng Cheng Han,Chin Yip Han,Lim Wen Hui,Syn Nicholas L.,Kamal Nur Haidah Bte Ahmad,Gupta Mehek,Heong Valerie,Lee Xiao Wen,Sapari Nur Sabrina,Koh Xue Qing,Isa Zul Fazreen Adam,Ho Lucius,O’Hara Caitlin,Ulagapan Arvindh,Gu Shi Yu,Shroff Kashyap,Weng Rei Chern,Lim Joey S. Y.,Lim Diana,Pang Brendan,Ng Lai Kuan,Wong Andrea,Soo Ross Andrew,Yong Wei Peng,Chee Cheng Ean,Lee Soo-Chin,Goh Boon-Cher,Soong Richie,Tan David S.P.
Abstract
PurposePrecision oncology, such as next generation sequencing (NGS) molecular analysis and bioinformatics are used to guide targeted therapies. The laboratory turnaround time (TAT) is a key performance indicator of laboratory performance. This study aims to formally apply statistical process control (SPC) methods such as CUSUM and EWMA to a precision medicine programme to analyze the learning curves of NGS and bioinformatics processes.Patients and MethodsTrends in NGS and bioinformatics TAT were analyzed using simple regression models with TAT as the dependent variable and chronologically-ordered case number as the independent variable. The M-estimator “robust” regression and negative binomial regression were chosen to serve as sensitivity analyses to each other. Next, two popular statistical process control (SPC) approaches which are CUSUM and EWMA were utilized and the CUSUM log-likelihood ratio (LLR) charts were also generated. All statistical analyses were done in Stata version 16.0 (StataCorp), and nominal P < 0.05 was considered to be statistically significant.ResultsA total of 365 patients underwent successful molecular profiling. Both the robust linear model and negative binomial model showed statistically significant reductions in TAT with accumulating experience. The EWMA and CUSUM charts of overall TAT largely corresponded except that the EWMA chart consistently decreased while the CUSUM analyses indicated improvement only after a nadir at the 82nd case. CUSUM analysis found that the bioinformatics team took a lower number of cases (54 cases) to overcome the learning curve compared to the NGS team (85 cases).ConclusionAs NGS and bioinformatics lead precision oncology into the forefront of cancer management, characterizing the TAT of NGS and bioinformatics processes improves the timeliness of data output by potentially spotlighting problems early for rectification, thereby improving care delivery.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献